Login
$XBIO
$1.49 -$0.17 (10.24%) Close

$XBIO 8-K/A SEC Filings

Filed On Filing
19 Mar 2025 8-K/A: Financial Statements and Exhibits

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers

20 May 2019 8-K/A: Other Events

THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED

13 May 2019 8-K/A: Other Events

THE SYMBOL “[****]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL, AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED

10 Apr 2014 8-K/A: Financial Statements and Exhibits

Consolidated Balance Sheets as of December 31, 2013 and 2012

05 Feb 2014 8-K/A: Unregistered Sales of Equity Securities

Reference is made to the disclosure set forth under Item 3.02 in our Current Report filed on Form 8-K on January 30, 2014, which disclosure is incorporated herein by reference. As discussed in this earlier disclosure, in January 2014 we ...

25 Nov 2013 8-K/A: Other Events

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. PART 2 (EXPLANATORY STATEMENT) OF THIS DOCUMENT COMPRISES AN EXPLANATORY STATEMENT IN COMPLIANCE WITH SECTION 897 OF THE COMPANIES ACT 2006. THIS DOCUMENT CONTAINS DETAILS...

14 Nov 2013 8-K/A: Other Events

On November 13, 2013, we filed a technical amendment to the joint announcement we made with Xenetic Biosciences plc (“XEN”) on November 12, 2013 regarding the terms of the recommended proposal for our Acquisition of the share capital of ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support